CEOInterviews.AI
Start App
Patrick Soon-Shiong
Founder, Executive Chairman and Global Chief Scientific and Medical Officer, ImmunityBio, Inc.

CES 2026 | Dr. Patrick Soon-Shiong | LATMG, Founder

📅 Jan 09, 2026 LA Times Studios 21 MIN 572 VIEWS 41 SEGMENTS · 2 SPEAKERS
Dr. Patrick Soon-Shiong, renowned medical doctor turned entrepreneur and owner of L.A. Times Media Group, discusses his company NANT Global Finance's bold effort to create a fully integrated, blockchain-enabled capital markets platform. The initiative could modernize how public stocks are traded and settled using regulated blockchain infrastructure — and to make that happen, NANT finalized the acquisition of certain key players in the fintech space. Soon-Shiong explains what makes this effort unique from past blockchain projects and what it might mean for the Los Angeles Times to be involved i...

Questions asked in this interview

10
  1. 0:26Tell me a little bit about that and then what brings you back today?
  2. 2:02And it's my impression that there are a lot of parts of that family. So, can you explain that?
  3. 3:23Can you say a little bit more about that now that you're here with me today now that you finally made it after nearly a decade?
  4. 5:31NantX, can you break down NantX for me?
  5. 7:18How does this stay true to your mission of connecting and empowering people?
  6. 10:05Now, me saying that is like me presenting in 2008 that machine vision, right?
  7. 11:30Is this what is the technology that allows you to do that?
  8. 13:24Is that what we can expect from the conference next week?
  9. 17:48What's one thing that excites you this year heading into 2026 about where we are moving in terms of something like AI?
  10. 19:50So to close, what is NantWorks?
Host 0:16 ↗
Welcome to CES 2026 in Las Vegas. I'm here at the foundry and I'm joined today by very special guest, Dr. Patrick Soon-shiong. Dr. Patrick, welcome.
Patrick Soon-shiong 0:25 ↗
Thank you for having me.
Host 0:26 ↗
Thank you so much for joining us. Now you are the person behind all of this where we are sitting today. You are the founder of NantWorks and the owner of the LA Times. Now the last time you were at CES I understand was quite a few years ago. Tell me a little bit about that and then what brings you back today?
Patrick Soon-shiong 0:45 ↗
Well, crazy as it may sound, the last time I was at CES was literally a decade ago, and we came there then to announce and release AI machine vision technology in which we could take the phone and actually image anything in the world and allow even the blind to see. The problem is it was 10 years ahead of its time. I literally then brought it to the LA Times then and said you can take every image and convert that image in real time into a video. And the problem with the feedback was who's going to be crazy enough to look through the camera of the iPhone. So if you want to go look at the website, it's still alive. We kept it alive called nantmobile.com. You will see all these videos there that will recognize images, videos, QR codes and money and even allow the blind to see. So in frustration we went stealth and it's been a decade of stealth in which NantWorks we have spent close to 3 to 4 billion dollars quietly across a multitude of companies all stealth as part of NantWorks.
Host 2:02 ↗
Well, break down NantWorks for me. What is NantWorks? And it's my impression that there are a lot of parts of that family. So, can you explain that?
Patrick Soon-shiong 2:10 ↗
So, look, I am a physician, surgeon, scientist, but I ran the California Nanosystems Institute at UCLA for 10 years, which integrated technology, networks, software, computing, and healthcare. So I believe that the biology of the human being of synapses, interconnectivity, messaging, AI, cancer is all connected. So I've used my knowledge of the biology of the human being and transferred that into digital technology that's happening in real time, including AI. I presented as early as 2010 to President Obama when he was president that AI would be the future of healthcare and I have a little thing called the rocket ship. I realized being ahead of time is really not the answer. So, let's go build the companies, execute on that vision, show real world technology quietly, stealthily, and this CES is where I'm going to be revealing the platform of NantWorks.
Host 3:23 ↗
Can you say a little bit more about that now that you're here with me today now that you finally made it after nearly a decade?
Patrick Soon-shiong 3:28 ↗
Right. Well, since I couldn't convince the LA Times, I think it was 2012, to go into the future, I bought it and here we are today. So, I bought it really to move it from what we call ink to digital. And as you could see today is the Los Angeles Times Media Group where we have not only the voice but we have the integrity of news but more importantly we have an opportunity to really inspire, teach, educate and engage and that's what LAMG is. So we can talk about NantWorks on the side of how would we engage with people. Then they talk about NantWorks in terms of how we would cure life-threatening diseases whether it be cancer, diabetes, HIV and in fact how we address aging. Then we can talk about NantWorks about how we need to save this planet. What do we need to do for energy? Then we need to talk about NantWorks about imagine we could move data at the speed of light. So that is NantWorks. NantWorks is an organization that's really taking the futuristic of technology which wasn't the future. It was here 10 years ago. We were part of the NASA I was a NASA scientist. The machine vision was founded by the scientists who developed Roomba and the development for the machine on Mars. I ran the national lambda rail which actually interconnected all the data centers for the Large Hadron Collider. So these are the things that I said look, rather than being noisy about it just develop each of them individual companies, bring them together under one umbrella called NantWorks and let the world understand when it's ready and 2026 it is ready and here I am.
Host 5:31 ↗
It's ready and we have some fresh new announcement. This is fresh off the press from my understanding. NantX, can you break down NantX for me? I know you just covered a lot. We're talking about data at the speed of light. Let's zoom in. NX.
Patrick Soon-shiong 5:45 ↗
So NX will be really partnered with the LAMG platform. We have now made a partnership with New York Stock Exchange floor where we will be as part of LAMG on the floor of New York Stock Exchange. And as I was walking through the New York Stock Exchange and ICE and as you see ICE which is the parent of New York Stock Exchange has now taken Polymarket and this is the future and I realize that the ability for a normal person in the public to want to own let's say a very expensive Berkshire Hathaway stock or an Apple stock, they should be able to participate and actually own a piece of that stock if that's all they can own. That's called tokenization. And if you can tokenize a stock but make it very very safe and secure and all under the regulatory framework of SEC and FINRA and use blockchain. So what happened is we were one of the first blockchain patents to have been developed. And I was approached by Mark Elements and the team and today you'll see the press release of Nant Global Finance and the platform that's going to be coming is called NantX which will allow anybody to own a piece of stock or trade on a global security exchange and have it really efficient and safe.
Host 7:18 ↗
How does this stay true to your mission of connecting and empowering people?
Patrick Soon-shiong 7:24 ↗
Because we have to empower everybody. Whether you're an African in the bush trying to make a living or whether you're the billionaire trying to make stock exchange or whether you want to be able to democratize with a small D the ability for everybody to share in this community and the stock market security exchange even asset exchange is a very difficult thing to do unless you have real time ability to know how to do that with a mobile app. So this is what this is. So NantX will be that platform that in real time you can not only see your stock immediately exchange it, immediately buy it, immediately own it and be secure through blockchain.
Host 8:13 ↗
Well, if NantX wasn't already a big enough announcement, I hear that you have another announcement that goes back again to your very storied resume of healthcare. Now tell me about all of the new and exciting things that you're developing with cancer that have to do with tech and AI and ties into where we are today CES 2026.
Patrick Soon-shiong 8:32 ↗
So the world knows me in healthcare all the way from a time I developed American Pharmaceutical Partners in which we had 150 FDA approved products and heparin caused sadly 86 deaths in the United States. We were the only safe supply of heparin which meant that the idea of having raw materials in the control of America as a national security would be a really key element. I then developed Abraxane which is a drug for cancer and sold it to Celgene. I decided then as part of this whole stealth movement to say the future of healthcare, future of cancer, future of diabetes, future of autoimmune disease is actually in your body. So let me explain that. You have you and I sitting here in our body have three cells. I mean much more than that but let's just talk about three cells: one called the natural killer cell, one called the killer T-cell, and one called the T-regulatory cell. What does that mean? Well, your natural killer cell has evolved for 450 million years to allow you to be protected from cancer, HIV, COVID, and even aging.
Host 10:05 ↗
Now, me saying that is like me presenting in 2008 that machine vision, right? Because I'm like I don't look 450 million years old. Explain that.
Patrick Soon-shiong 10:16 ↗
Well, thank God. But this cell got evolved from a time literally from the ocean for mammals to exist and it evolved from 450 million years so that a cell from my body can be given to you without any reaction. The cell from anybody's so it's really been evolved so that it can be allowed to be cross-reacted. So I realized that this natural killer cell for cancer for example just like you go to the Red Cross to get red blood cells for a blood transfusion we could have natural killer cells as a Red Cross of cancer.
Host 11:01 ↗
Well, how do you? How is the question.
Patrick Soon-shiong 11:07 ↗
So if I then took a donation of blood from you like you give blood and extracted white cells and deconstructed those white cells into these three components that I'm just talking about and grew them into billions of cells froze them down that became the American Red Cross of cancer.
Host 11:30 ↗
So I ask you again, how is there a machine? Is this what is the technology that allows you to do that?
Patrick Soon-shiong 11:36 ↗
So let's talk about the why and then we'll talk about the how.

21 more exchanges in this transcript

Sign in free to read the rest of this interview. No card required.

Sign in to read the full transcript

Cite this transcript

APA, MLA, BibTeX
APA

Soon-Shiong, P. (2026, January 9). CES 2026 | Dr. Patrick Soon-Shiong | LATMG, Founder [Interview transcript]. LA Times Studios. CEOInterviews.AI. https://ceointerviews.ai/interview/628836/

MLA

Patrick Soon-Shiong. "CES 2026 | Dr. Patrick Soon-Shiong | LATMG, Founder." LA Times Studios, 9 Jan. 2026. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/628836/.

BibTeX
@misc{soonshiong2026_628836,
  author       = {Patrick Soon-Shiong},
  title        = {CES 2026 | Dr. Patrick Soon-Shiong | LATMG, Founder},
  howpublished = {Interview transcript, LA Times Studios. CEOInterviews.AI},
  year         = {2026},
  month        = {jan},
  url          = {https://ceointerviews.ai/interview/628836/},
  note         = {Speaker-attributed transcript with timestamps}
}